Which first- degree relatives of patients with colorectal neoplasias are at the highest risk
Authors:
I. Mikoviny Kajzrlíková 1; P. Vítek 1,2; J. Chalupa 1; Petr Dítě 2
Authors place of work:
Beskydské Gastrocentrum Interního oddělení Nemocnice ve Frýdku– Místku, p. o., Frýdek– Místek, vedoucí Gastrocentra MU Dr. Petr Vítek, Ph. D.
1; Katedra interních oborů Lékařské fakulty UO Ostrava, vedoucí katedry MU Dr. Ivo Valkovský
2
Published in the journal:
Vnitř Lék 2013; 59(4): 264-268
Category:
Original Contributions
Předneseno nebo publikováno ve formě posteru: Rožnovské gastroenterologické dny, Rožnov pod Radhoštěm, 2011; Konference mladých lékařů, Brno, 2011; Dny mladých internistů, Olomouc, 2011; Kongres České gastroenterologické společnosti, Brno, 2011; Národní kongres o kolorektálním karcinomu, Praha, 2011; United European Gastroenterology week, Stockholm, 2011
Summary
Background and aims:
The first-degree relatives of patients with colorectal neoplasias have higher risk of colorectal cancer than general population. The aim of our study was to identify first- degree relatives at the highest risk of colorectal neoplasia considering both their hereditary and non‑hereditary risks.
Methods:
We have analysed the results of colonoscopic examinations of the first- degree relatives done within the project and we have compared them with the epidemiologic data relevant to colorectal cancer that we obtained from first-degree relatives.
Results:
160 first- degree relatives (66 men, 94 women, mean age 48.2, SD ± 10.9 years) have undergone colonoscopic examination within the project, 105 (66 %) of them had no or non‑neoplastic polyps, 55 (34 %) had neoplastic lesions. In the univariate analysis the risk factors for the occurence of neoplastic lesions were: male sex (OR 2.30, 95% CI 1.18– 4.48, p = 0.014), age over 50 years (OR 2.78, 95% CI 1.42– 5.45, p = 0.003), sibship (OR 2.71, 95% CI 1.25– 5.87, p = 0.012), smoking (OR 2.37, 95% CI 1.21– 4.63, p = 0.012) and higher fat intake (OR 2.07, 95% CI 1.07– 4.04, p = 0.032). In the multivariate analysis only the age over 50 years proved significant (OR 2.84, 95% CI 1.32– 6.09, p = 0.007). The most of the neoplastic lesions in first- degree relatives were located in the right colon.
Conclusions:
We can confirm high prevalence of neoplastic lesions among first- degree relatives. First-degree relatives at the highest risk are men over 50 years of age, siblings, smokers, who do not reduce dietary fat intake. This group of patients share both genetic and environmental risks and thus should be screened with the highest priority.
Key words:
colorectal cancer – first– degree relatives – dietary habits – risk factors
Zdroje
1. Novotvary 2008 ČR (Cancer Incidence 2008 in the Czech Republic). ÚZIS ČR: Praha 2008.
2. Manser CN, Bachmann LM, Brunner H et al. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma‑related death: a closed cohort study. Gastrointest Endosc 2012; 76: 110– 117.
3. Brenner H, Altenhofen L, Hoffmeister M. Sex, age, and birth cohort effects in colorectal neoplasms: a cohort analysis. Ann Intern Med 2010; 152: 697– 703.
4. Winawer SJ, Schottenfeld D, Flehinger BJ. Colorectal cancer screening. J Natl Cancer Inst 1991; 83: 243– 253.
5. Norat T, Bingham S, Ferrari P et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 2005; 97: 906– 916.
6. Botteri E, Iodice S, Bagnardi V et al. Smoking and colorectal cancer: a meta‑analysis. JAMA 2008; 300: 2765– 2778.
7. Cho E, Smith- Warner SA, Ritz J et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 2004; 140: 603– 613.
8. Renehan AG, Tyson M, Egger M et al. Body‑mass index and incidence of cancer: a systematic review and meta‑analysis of prospective observational studies. Lancet 2008; 371: 569– 578.
9. Chan AO, Jim MH, Lam KF et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA 2007; 298: 1412– 1419.
10. Ma J, Pollak MN, Giovannucci E et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin‑like growth factor (IGF)- I and IGF‑binding protein‑3. J Natl Cancer Inst 1999; 91: 620– 625.
11. Johns LE, Houlston RS. A systematic review and meta‑analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96: 2992– 3003.
12. Neklason DW, Thorpe BL, Ferrandez A et al. Colonic adenoma risk in familial colorectal cancer – a study of six extended kindreds. Am J Gastroenterol 2008; 103: 2577– 2584.
13. Wark PA, Wu K, van ‚t Veer P et al. Family history of colorectal cancer: a determinant of advanced adenoma stage or adenoma multiplicity? Int J Cancer 2009; 125: 413– 420.
14. Cottet V, Pariente A, Nalet B et al. Colonoscopic screening of first- degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 2007; 133: 1086– 1092.
15. Almendingen K, Hofstad B, Vatn MH. Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas? Gut 2003; 52: 747– 751.
16. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009; 104: 739– 750.
17. Tytherleigh MG, Ng VV, Mathew LO et al. Colonoscopy for screening and follow up of patients with a family history of colorectal cancer. Colorectal Dis 2008; 10: 506– 511.
18. Martínez ME, Baron JA, Lieberman DA et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009; 136: 832– 841.
19. Martínez ME, Sampliner R, Marshall JR et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001; 120: 1077– 1083.
20. Armelao F, Paternolli C, Franceschini G et al. Colonoscopic findings in first- degree relatives of patients with colorectal cancer: a population‑based screening program. Gastrointest Endosc 2011; 73: 527– 534.
21. Lindgren G, Liljegren A, Jaramillo E et al. Adenoma prevalence and cancer risk in familial non‑polyposis colorectal cancer. Gut 2002; 50: 228– 234.
22. Bujanda L, Sarasqueta C, Zubiaurre L et al. Low adherence to colonoscopy in the screening of first– degree relatives of patients with colorectal cancer. Gut 2007; 56: 1714– 1718.
23. Menges M, Fischinger J, Gärtner B et al. Screening colonoscopy in 40- to 50‑year– old first– degree relatives of patients with colorectal cancer is efficient: a controlled multicentre study. Int J Colorectal Dis 2006; 21: 301– 307.
24. Suchanek S, Zavoral M, Majek O et al. National colorectal cancer screening programme in the Czech republic. Gut 2010; 59: A 84.
25. Jasperson KW, Tuohy TM, Neklason DW et al. Hereditary and familial colon cancer. Gastroenterology 2010; 138: 2044– 2058.
26. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology 2001; 121: 282– 301.
27. Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome– wide association studies. Nat Rev Genet 2009; 10: 353– 358.
28. Kerber RA, Slattery ML, Potter JD et al. Risk of colon cancer associated with a family history of cancer or colorectal polyps: the diet, activity, and reproduction in colon cancer study. Int J Cancer 1998; 78: 157– 160.
29. Pezzoli A, Matarese V, Rubini M et al. Colorectal cancer screening: results of a 5‑year program in asymptomatic subjects at increased risk. Dig Liver Dis 2007; 39: 33– 39.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2013 Číslo 4
Najčítanejšie v tomto čísle
- Aortic stenosis
- Lung metastases as the first manifestations of occult medullary microcarcinoma
- The „Short Physical Performance Battery“ in the Czech Republic – the pilot and validation study in older persons
- Perindopril in the treatment of hypertension and cardiovascular diseases: evolution continues with the orodispersible dosage form